Acrivon Therapeutics Inc.... (ACRV)
NASDAQ: ACRV
· Real-Time Price · USD
1.33
0.03 (2.31%)
At close: Sep 05, 2025, 3:59 PM
Acrivon Therapeutics Common Stock Revenue
Acrivon Therapeutics Common Stock reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending June 30, 2025, Acrivon Therapeutics Common Stock generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
0
Employees
75
Market Cap
41.83M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|---|---|
Dec 31, 2024 | 0 | n/a |
Dec 31, 2023 | 0 | n/a |
Dec 31, 2022 | 0 | n/a |
Dec 31, 2021 | 0 | n/a |
Dec 31, 2020 | 0 | n/a |